ConductScience.org, home

Paper39593161

Toll-Like receptor 3-mediated interferon-β production is suppressed by oncostatin m and a broader epithelial-mesenchymal transition program.

Chernosky NM and 5 others. Breast Cancer Res, 2024. Cited by 1 paper, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Toll-Like receptor 3-mediated interferon-β production is suppressed by oncostatin m and a broader epithelial-mesenchymal transition program. Papers, record 39593161. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39593161

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Toll-Like receptor 3-mediated interferon-β production is suppressed by oncostatin m and a broader epithelial-mesenchymal transition program.
PubMed
Journal
Breast Cancer Res
PubMed
Year
2024
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
1
iCite
Relative citation ratio, by iCite
0.16, provisional
iCite
Revised in PubMed
2026-10-11
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chernosky NMNoah M
2Tamagno IIlaria
3Polak KLKelsey L
4Chan ERE Ricky
5Yuan XXueer
6Jackson MWMark W

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Oncostatin MMajor topic
Epithelial-Mesenchymal TransitionMajor topic
Interferon-betaMajor topic
Toll-Like Receptor 3Major topic
Triple Negative Breast NeoplasmsMajor topic
Tumor MicroenvironmentMajor topic
Humans
Cell Line, Tumor
Female
Gene Expression Regulation, Neoplastic
Signal Transduction
Zinc Finger E-box-Binding Homeobox 1
Cell Movement

Source PubMed

Download CSV of topics

Grants7

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
S10 OD024981NIH HHSUnited StatesS10OD024981PubMedNIH RePORTER
R01CA252224NIH HHSUnited StatesR01CA252224PubMed and NIHNIH RePORTER
P01 CA272161NCI NIH HHSUnited StatesP01CA272161PubMedNIH RePORTER
R01 CA252224NCI NIH HHSUnited StatesR01CA252224PubMed and NIHNIH RePORTER
W81XWH-20-1-0464; BC191534US Department of Defense Breast Cancer Research ProgramPubMedPubMed
P30 DK097948NIDDK NIH HHSUnited StatesP30DK097948PubMedNIH RePORTER
P30 CA043703NCI NIH HHSUnited StatesP30CA043703PubMedNIH RePORTER

Download CSV of grants

References85

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
124434209Targeting the tumor microenvironment with interferon-β bridges innate and adaptive immune responses.Cancer Cell2014https://conductscience.org/library/papers/24434209PubMed
224398568High efficiency cell-specific targeting of cytokine activity.Nat Commun2014https://conductscience.org/library/papers/24398568PubMed
324652403Tumor-induced STAT3 activation in monocytic myeloid-derived suppressor cells enhances stemness and mesenchymal properties in human pancreatic cancer.Cancer Immunol Immunother2014https://conductscience.org/library/papers/24652403PubMed
430190477LY6E mediates an evolutionarily conserved enhancement of virus infection by targeting a late entry step.Nat Commun2018https://conductscience.org/library/papers/30190477PubMed
536876871cGAS-STING signalling in cancer: striking a balance with chromosomal instability.Biochem Soc Trans2023https://conductscience.org/library/papers/36876871PubMed
631036052The opposing effects of interferon-beta and oncostatin-M as regulators of cancer stem cell plasticity in triple-negative breast cancer.Breast Cancer Res2019https://conductscience.org/library/papers/31036052PubMed
715733829Transcriptional signaling by double-stranded RNA: role of TLR3.Cytokine Growth Factor Rev2005https://conductscience.org/library/papers/15733829PubMed
816757721Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.JAMA2006https://conductscience.org/library/papers/16757721PubMed
925453096Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells.Proc Natl Acad Sci U S A2014https://conductscience.org/library/papers/25453096PubMed
1022328912Interferon-stimulated genes and their antiviral effector functions.Curr Opin Virol2011https://conductscience.org/library/papers/22328912PubMed
1137333017Circulating neutrophils activated by cancer cells and M2 macrophages promote gastric cancer progression during PD-1 antibody-based immunotherapy.Front Mol Biosci2023https://conductscience.org/library/papers/37333017PubMed
1225344738Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy.Nat Med2014https://conductscience.org/library/papers/25344738PubMed
1334414698Toll-like receptor 3 (TLR3) regulation mechanisms and roles in antiviral innate immune responses.J Zhejiang Univ Sci B2021https://conductscience.org/library/papers/34414698PubMed
1430450098Both Type I and Type II Interferons Can Activate Antitumor M1 Macrophages When Combined With TLR Stimulation.Front Immunol2018https://conductscience.org/library/papers/30450098PubMed
1532477956Pharmacological STING Activation Is a Potential Alternative to Overcome Drug-Resistance in Melanoma.Front Oncol2020https://conductscience.org/library/papers/32477956PubMed
1619567251ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays.J Immunol Methods2009https://conductscience.org/library/papers/19567251PubMed
1731564637An Evolutionarily Conserved Function of Polycomb Silences the MHC Class I Antigen Presentation Pathway and Enables Immune Evasion in Cancer.Cancer Cell2019https://conductscience.org/library/papers/31564637PubMed
1835192545Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment.J Clin Invest2022https://conductscience.org/library/papers/35192545PubMed
1925430879Type I IFN gene delivery suppresses regulatory T cells within tumors.Cancer Gene Ther2014https://conductscience.org/library/papers/25430879PubMed
2028848054Neoadjuvant Interferons: Critical for Effective PD-1-Based Immunotherapy in TNBC.Cancer Immunol Res2017https://conductscience.org/library/papers/28848054PubMed

See all 85 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
40868199Cytokine Networks in Triple-Negative Breast Cancer: Mechanisms, Therapeutic Targets, and Emerging Strategies.Biomedicines2025https://conductscience.org/library/papers/40868199

Source PubMed

Download CSV of cited by

Genes7

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
IFNA13439PubTator's text mininghttps://conductscience.org/library/genes/3439NCBI Gene
IFNB13456PubTator's text mininghttps://conductscience.org/library/genes/3456NCBI Gene
OSM5008PubTator's text mininghttps://conductscience.org/library/genes/5008NCBI Gene
SNAI16615PubTator's text mininghttps://conductscience.org/library/genes/6615NCBI Gene
TGFB17040PubTator's text mininghttps://conductscience.org/library/genes/7040NCBI Gene
TLR37098PubTator's text mininghttps://conductscience.org/library/genes/7098NCBI Gene
ZEB16935PubTator's text mininghttps://conductscience.org/library/genes/6935NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39593161

GET https://conductscience.org/api/papers/v1/39593161/references?page=2